{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:49:41Z","timestamp":1740142181992,"version":"3.37.3"},"reference-count":23,"publisher":"Bentham Science Publishers Ltd.","issue":"6","funder":[{"DOI":"10.13039\/501100011665","name":"King Saud University","doi-asserted-by":"publisher","award":["RG -1436-013"],"award-info":[{"award-number":["RG -1436-013"]}],"id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008982","name":"Qatar National Research Funds","doi-asserted-by":"publisher","award":["NPRP10-0207-170385"],"award-info":[{"award-number":["NPRP10-0207-170385"]}],"id":[{"id":"10.13039\/100008982","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CVP"],"published-print":{"date-parts":[[2020,9,17]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>The prognostic impact of beta-blockers (BB) in coronary artery disease (CAD) is controversial,\nespecially in the post-reperfusion era. We studied in-hospital cardiovascular events in patients hospitalized\nfor acute HF, a previous history of CAD and a left ventricular ejection fraction (LVEF) &amp;#8805;40%,\nin relation to BB on admission; and 1-year outcome in relation to BB on discharge, in the GULF aCute\nheArt failuRe (GULF-CARE) registry. From a total of 5005 patients included in the GULF-CARE registry,\n303 patients with a previous history of CAD and a LVEF &amp;#8805;40% on BB were propensity-matched\nto 303 patients without BB on admission. In-hospital mortality (OR= 0.82; 95% CI [0.35-1.94]), stroke\nand cardiogenic shock were not reduced by BB. On discharge, 306 patients on BB, including the ones\nnewly diagnosed with myocardial infarction as a precipitating cause of HF, were propensity-scored\nmatched with 306 patients without BB. Mortality (OR= 0.86; 95%CI [0.51-1.45], hospitalization for HF\nor PCI\/CABG at 1 year were also not reduced by BB at discharge. In summary, our data show that BB\nhave a neutral effect on in-hospital and 1-year outcomes in acute heart failure patients with a previous\nhistory of CAD and a LVEF &amp;#8805;40%.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570161118666191231114203","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T12:51:57Z","timestamp":1577796717000},"page":"644-651","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Beta-Blockers and Cardiovascular Outcomes in Acute Heart Failure with a History of Coronary Artery Disease and an Ejection Fraction \u2265 40%"],"prefix":"10.2174","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1428-6324","authenticated-orcid":true,"given":"Charbel","family":"Abi Khalil","sequence":"first","affiliation":[{"name":"Heart Hospital, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadhim","family":"Sulaiman","sequence":"additional","affiliation":[{"name":"National Heart Center, Royal Hospital, Muscat, Oman"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidal","family":"Asaad","sequence":"additional","affiliation":[{"name":"Heart Hospital, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid F.","family":"AlHabib","sequence":"additional","affiliation":[{"name":"Department of Cardiac Sciences, King Fahad Cardiac Center, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alawi","family":"Alsheikh-Ali","sequence":"additional","affiliation":[{"name":"College of Medicine Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Jameesh","sequence":"additional","affiliation":[{"name":"Heart Hospital, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Al-Jarallah","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sabah Al-Ahmed Cardiac Center, Kuwait City, Kuwait"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassam","family":"Bulbanat","sequence":"additional","affiliation":[{"name":"Department of Medicine, Al-Amiri Hospital, Kuwait City, Kuwait"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael","family":"AlMahmeed","sequence":"additional","affiliation":[{"name":"Heart and Vascular Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Ridha","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Adan Hospital, Kuwait City, Kuwait"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nooshin","family":"Bazargani","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Dubai Hospital, Dubai, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitham","family":"Amin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mohammed Bin Khalifa Cardiac Center, Manamah, Bahrain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Al-Motarreb","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Sana\u2019a University, Sana\u2019a, Yemen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Husam","family":"AlFaleh","sequence":"additional","affiliation":[{"name":"Department of Cardiac Sciences, King Fahad Cardiac Center, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashanth","family":"Panduranga","sequence":"additional","affiliation":[{"name":"National Heart Center, Royal Hospital, Muscat, Oman"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyad","family":"Mahfoud","sequence":"additional","affiliation":[{"name":"Biostatistics, Epidemiology and BioMathematical Research Core, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jassim","family":"Al Suwaidi","sequence":"additional","affiliation":[{"name":"Heart Hospital, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"f55","DOI":"10.1136\/bmj.f55","volume":"346","author":"Chatterjee S.","year":"2013","unstructured":"Chatterjee S.; Biondi-Zoccai G.; Abbate A.; Benefits of \u03b2 blockers in patients with heart failure and reduced ejection fraction: network meta-analysis. BMJ 2013,346,f55","journal-title":"BMJ"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.ijcard.2012.10.050","volume":"168","author":"Chatterjee S.","year":"2013","unstructured":"Chatterjee S.; Chaudhuri D.; Vedanthan R.; Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials. Int J Cardiol 2013,168(2),915-921","journal-title":"Int J Cardiol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.amjmed.2014.05.032","volume":"127","author":"Bangalore S.","year":"2014","unstructured":"Bangalore S.; Makani H.; Radford M.; Clinical outcomes with \u03b2-blockers for myocardial infarction: a meta-analysis of randomized trials. Am J Med 2014,127(10),939-953","journal-title":"Am J Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"i4801","DOI":"10.1136\/bmj.i4801","volume":"354","author":"Puymirat E.","year":"2016","unstructured":"Puymirat E.; Riant E.; Aissaoui N.; \u03b2-Blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study. BMJ 2016,354,i4801","journal-title":"BMJ"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1056\/NEJMcp1511175","volume":"375","author":"Redfield M.M.","year":"2016","unstructured":"Redfield M.M.; Heart failure with preserved ejection fraction. N Engl J Med 2016,375(19),1868-1877","journal-title":"N Engl J Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.4065\/mcp.2010.0841","volume":"86","author":"Oghlakian G.O.","year":"2011","unstructured":"Oghlakian G.O.; Sipahi I.; Fang J.C.; Treatment of heart failure with preserved ejection fraction: have we been pursuing the wrong paradigm? Mayo Clin Proc 2011,86(6),531-539","journal-title":"Mayo Clin Proc"},{"key":"ref=7","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007631","volume":"6","author":"Abi Khalil C.","year":"2017","unstructured":"Abi Khalil C.; AlHabib K.F.; Singh R.; \u03b2-Blocker therapy prior to admission for acute coronary syndrome in patients without heart failure or left ventricular dysfunction improves in-hospital and 12-month outcome: results from the GULF-RACE 2 (Gulf Registry of Acute Coronary Events-2). J Am Heart Assoc 2017,6(12)","journal-title":"J Am Heart Assoc"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/ejhf.245","volume":"17","author":"Sulaiman K.","year":"2015","unstructured":"Sulaiman K.; Panduranga P.; Al-Zakwani I.; Clinical characteristics, management, and outcomes of acute heart failure patients: observations from the Gulf acute heart failure registry (Gulf CARE). Eur J Heart Fail 2015,17(4),374-384","journal-title":"Eur J Heart Fail"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/S0140-6736(14)61889-4","volume":"385","author":"Braunwald E.","year":"2015","unstructured":"Braunwald E.; The war against heart failure: the Lancet lecture. Lancet 2015,385(9970),812-824","journal-title":"Lancet"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2174\/1570161114666160822155440","volume":"15","author":"Abi Khalil C.","year":"2017","unstructured":"Abi Khalil C.; Al Suwaidi J.; Singh R.; Beta-Blockers are associated with decreased in-hospital mortality and stroke in acute decompensated heart failure: findings from a retrospective analysis of a 22-year registry in the Middle East (1991-2013). Curr Vasc Pharmacol 2017,15(1),77-83","journal-title":"Curr Vasc Pharmacol"},{"key":"ref=11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-014915","volume":"7","author":"Abi Khalil C.","year":"2017","unstructured":"Abi Khalil C.; Sulaiman K.; Mahfoud Z.; Non-withdrawal of beta blockers in acute decompensated chronic and de novo heart failure with reduced ejection fraction in a prospective multicentre study of patients with acute heart failure in the Middle East. BMJ Open 2017,7(7)","journal-title":"BMJ Open"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1161\/CIR.0b013e31829e8776","volume":"128","author":"Yancy C.W.","year":"2013","unstructured":"Yancy C.W.; Jessup M.; Bozkurt B.; 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation\/American heart association task force on practice guidelines. Circulation 2013,128(16),e240-e327","journal-title":"Circulation"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","volume":"14","author":"McMurray J.J.","year":"2012","unstructured":"McMurray J.J.; Adamopoulos S.; Anker S.D.; Task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology; esc committee for practice guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012,14(8),803-869","journal-title":"Eur J Heart Fail"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijcard.2016.11.239","volume":"228","author":"Fukuta H.","year":"2017","unstructured":"Fukuta H.; Goto T.; Wakami K.; Ohte N.; The effect of beta-blockers on mortality in heart failure with preserved ejection fraction: A meta-analysis of observational cohort and randomized controlled studies. Int J Cardiol 2017,228,4-10","journal-title":"Int J Cardiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.jacc.2009.02.046","volume":"53","author":"van Veldhuisen D.J.","year":"2009","unstructured":"van Veldhuisen D.J.; Cohen-Solal A.; B\u00f6hm M.; Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). J Am Coll Cardiol 2009,53(23),2150-2158","journal-title":"J Am Coll Cardiol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/eurjhf\/hfs141","volume":"15","author":"Yamamoto K.","year":"2013","unstructured":"Yamamoto K.; Origasa H.; Hori M.; Investigators J.D.; Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese diastolic heart failure study (J-DHF). Eur J Heart Fail 2013,15(1),110-118","journal-title":"Eur J Heart Fail"},{"key":"ref=17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012721.pub2","volume":"6","author":"Martin N.","year":"2018","unstructured":"Martin N.; Manoharan K.; Thomas J.; Davies C.; Lumbers R.T.; Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction. Cochrane Database Syst Rev 2018,6","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/1874192401610010035","volume":"10","author":"Kiselev A.R.","year":"2016","unstructured":"Kiselev A.R.; Shvartz V.A.; Karavaev A.S.; Correlations between cardiovascular autonomic control indices during the two-hour immobilization test in healthy subjects. Open Cardiovasc Med J 2016,10,35-43","journal-title":"Open Cardiovasc Med J"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2459\/JCM.0b013e3283512199","volume":"13","author":"Kiselev A.R.","year":"2012","unstructured":"Kiselev A.R.; Gridnev V.I.; Prokhorov M.D.; Selection of optimal dose of beta-blocker treatment in myocardial infarction patients based on changes in synchronization between 0.1 Hz oscillations in heart rate and peripheral microcirculation. J Cardiovasc Med (Hagerstown) 2012,13(8),491-498","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/eurheartj\/ehv087","volume":"36","author":"Floras J.S.","year":"2015","unstructured":"Floras J.S.; Ponikowski P.; The sympathetic\/parasympathetic imbalance in heart failure with reduced ejection fraction. Eur Heart J 2015,36(30),1974-1982","journal-title":"Eur Heart J"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ccl.2013.09.010","volume":"32","author":"Zhang D.Y.","year":"2014","unstructured":"Zhang D.Y.; Anderson A.S.; The sympathetic nervous system and heart failure. Cardiol Clin 2014,32(1),33-45","journal-title":"Cardiol Clin"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1161\/01.RES.0000102042.83024.CA","volume":"93","author":"Lohse M.J.","year":"2003","unstructured":"Lohse M.J.; Engelhardt S.; Eschenhagen T.; What is the role of beta-adrenergic signaling in heart failure? Circ Res 2003,93(10),896-906","journal-title":"Circ Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","volume":"32","author":"Borlaug B.A.","year":"2011","unstructured":"Borlaug B.A.; Paulus W.J.; Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J 2011,32(6),670-679","journal-title":"Eur Heart J"}],"container-title":["Current Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/177939","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/177939\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/177939","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T15:42:54Z","timestamp":1609774974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/177939\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,9,17]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570161118666191231114203","relation":{},"ISSN":["1570-1611"],"issn-type":[{"type":"print","value":"1570-1611"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-09-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}